READ-ONLY DIGITIZATION RESULT
Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma.
EBioMedicine · 2024-Dec · PMID 39631145
Panel C提取完成待 EXE 对齐验证
Progression Free Survival
Fig. 4 Progression-free survival stratified by CD8A gene expression in the discovery and validation cohorts, and CD8A/rituximab interaction analysis. A) TROG99.03 discovery cohort. B) AusESFL validation cohort. C) CanESFL validation cohort. D) TROG99. 03 discovery cohort stratified by rituximab use and CD8A gene expression.
算法:legacy-0.5.0引擎:enhanced-linux
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | complete | 待验证 | 2 | 2026-07-23T18:34:36+00:00 |